Drug Price Transparency in Medicaid Act of 2023
Last action on Sep 4, 2025Held at the desk.
Take Action
Bill text replaced
This bill's text was replaced via an amendment in the nature of a substitute. Some metadata (subjects, policy area, committees) may reflect the original bill and not the current text.
Summary
Drug Price Transparency in Medicaid Act of 2023
This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions and survey participation to be made publicly available.
